Early-onset Alzheimer’s: new drug shows promise in slowing the disease
But new data from a recent clinical trial suggests that a previously discontinued experimental drug, called gantenerumab, ...
ScienceAlert1h
Sometimes Alzheimer's Strikes Early. This Experimental Drug May Help.
But new data from a recent clinical trial suggests that a previously discontinued experimental drug, called gantenerumab, ...
AFib diagnosed in midlife linked to 21% increased risk of dementia at any age, 36% higher risk of early-onset dementia
New research presented at the EHRA 2025, a scientific congress of the European Society of Cardiology, shows that the presence ...
The Print1d
Early-onset Alzheimer’s: new drug shows promise in slowing disease
Alzheimer’s disease is usually associated with old age. But around 5%-10% of all Alzheimer’s cases occur in people under the age of 65. Early-onset Alzheimer’s disease progresses more rapidly and ...
Medical News Today10d
Anti-amyloid drug may help reduce the risk of early-onset Alzheimer's by 50%
An early Alzheimer's treatment that removes amyloid plaques from the brain many years before symptoms arise may help delay ...
New drug could reduce risk of early-onset Alzheimer’s disease
The results boost hopes similar treatments being developed to target more common forms of Alzheimer’s – that appear when ...
New Atlas9d
Alzheimer’s prevention hope as drug cuts deadly disease onset in half
A long-term human trial has found that a discontinued drug halved the presentation of early-onset Alzheimer's disease in ...
Breakthrough Drug Cuts Alzheimer’s Risk by 50% in High-Risk Patients
A clinical trial involving individuals genetically predisposed to develop early-onset Alzheimer’s disease suggests that ...
The Independent10d
New drug could reduce risk of early-onset Alzheimer’s disease
Although the trial was limited to people with genetic forms of Alzheimer’s that lead to early onset, researchers expect that the study’s results will inform prevention and treatment efforts ...
Science Daily10d
Anti-amyloid drug shows signs of preventing Alzheimer's dementia
An experimental drug appears to reduce the risk of Alzheimer's-related dementia in people destined to develop the disease in their 30s, 40s or 50s, according to the results of a new study. The ...